News and Insights from Our Multidisciplinary Team of Experts
Cambridge, MA and Westminster, CO — May 12, 2021 — Leap Therapeutics (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, and Flagship Biosciences, the leader in data-centric pathology and tissue analysis, today...
Laboratory Developed Test for Manual and Image Analysis-assisted Pathologist InterpretationCambridge, MA and Westminster, CO – April 12, 2021 — Flagship Biosciences, the leader in data-centric pathology and tissue analysis, and Leap Therapeutics (Nasdaq: LPTX), a...
Dr. Roberto Gianani and Michael Koratich Named to Key Medical and Pharma RolesWestminster, CO – March 10, 2021 – Flagship Biosciences, the leader in data-centric pathology and tissue analysis, today announced strategic additions to its executive team. Dr. Roberto...
Patent Number 10,839,512 Issued for New Tissue Sample Image Dot Detection MethodWestminster, CO – February 17, 2021 – Flagship Biosciences, the leader in data-centric pathology tissue analysis, today announced that the United States Patent and Trademark Office has...
The new technical partnership between Inspirata and Flagship Biosciences provides clinicians with a seamless, fully automated AI send-out solution, offering significant advantages over standard material transfers.Tampa, FL and Westminster, CO – (Globe Newswire)...
As one of the industry’s leading tissue data and image analysis services providers, Flagship Biosciences was recently selected as a Top Image Analysis Solution Provider for 2020. With advanced tissue image analysis solutions that give pharmaceutical and diagnostics...
Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.
PUBLICATIONS/POSTERS
Key takeaways An image analysis-based algorithm was used to assess CD8 expression in numerous tumor nests in non-small cell lung cancer, bladder, and melanoma tumor samples Measuring CD8 expression within tumor nests rather than averaging across a whole tissue section...
Summary View a scientific, collaborative success with our client, Heat Biologics, presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 medical oncology conference. We cover image analysis of tumor infiltrating lymphocytes (TIL) and more.
ABSTRACT PD-L1 positivity in tumor-associated macrophages has been related to a favorable response to anti-PD-1 and PD-L1 targeted therapies. This concept has driven interest in specifically identifying macrophages in PD-L1 stained tissues, but pathologists often have...
EVENTS
Visit Flagship at the Spatial Biology for Drug Development Summit. October 11-13, 2023. Join us at the inaugural Spatial Biology for Drug Development Summit to explore implementation strategies, challenges in interpretation, and how this rapidly changing technology is...
Visit us at booth E30 to learn how we can partner for end-to-end support of your research and development program. We help you analyze more data in more depth, so you can produce more effective therapies. Attending the 13th Annual World Clinical Biomarkers & CDx...
Flagship Bioscience is your source for spatial biology expertise, moving your research forward every step of the way. Our mission is to explore complex biomarkers within the context of disease in order to advance your precision medicine strategy. Attending the 2023...